Aerovate Therapeutics Dirección
Dirección controles de criterios 2/4
Actualmente no disponemos de información suficiente sobre el CEO.
Información clave
Tim Noyes
Chief Executive Officer (CEO)
US$3.1m
Compensación total
| Porcentaje del salario del CEO | 19.1% |
| Permanencia del CEO | 3.5yrs |
| Participación del CEO | n/a |
| Permanencia media de la dirección | 3yrs |
| Promedio de permanencia en la Junta Directiva | 3.5yrs |
Actualizaciones recientes de la dirección
Recent updates
Here's Why Aerovate Therapeutics (NASDAQ:AVTE) Must Use Its Cash Wisely
Oct 01
Aerovate: Imatinib Delivery Change Leads To Targeting Of Massive PAH Market
Jun 11Here's Why We're Watching Aerovate Therapeutics' (NASDAQ:AVTE) Cash Burn Situation
May 24Aerovate Therapeutics (NASDAQ:AVTE) Is In A Good Position To Deliver On Growth Plans
Feb 09We're Not Very Worried About Aerovate Therapeutics' (NASDAQ:AVTE) Cash Burn Rate
Oct 17Aerovate Therapeutics (NASDAQ:AVTE) Is In A Good Position To Deliver On Growth Plans
Jul 04Aerovate Therapeutics (NASDAQ:AVTE) Is In A Good Position To Deliver On Growth Plans
Feb 28A Look At The Fair Value Of Aerovate Therapeutics, Inc. (NASDAQ:AVTE)
Jan 06Companies Like Aerovate Therapeutics (NASDAQ:AVTE) Are In A Position To Invest In Growth
Oct 14Here's Why We're Not Too Worried About Aerovate Therapeutics' (NASDAQ:AVTE) Cash Burn Situation
Jul 01We Think Aerovate Therapeutics (NASDAQ:AVTE) Can Afford To Drive Business Growth
Jan 22Companies Like Aerovate Therapeutics (NASDAQ:AVTE) Are In A Position To Invest In Growth
Sep 30Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$85m |
| Jun 30 2024 | n/a | n/a | -US$88m |
| Mar 31 2024 | n/a | n/a | -US$82m |
| Dec 31 2023 | US$3m | US$586k | -US$76m |
| Sep 30 2023 | n/a | n/a | -US$70m |
| Jun 30 2023 | n/a | n/a | -US$64m |
| Mar 31 2023 | n/a | n/a | -US$57m |
| Dec 31 2022 | US$704k | US$563k | -US$52m |
| Sep 30 2022 | n/a | n/a | -US$45m |
| Jun 30 2022 | n/a | n/a | -US$37m |
| Mar 31 2022 | n/a | n/a | -US$31m |
| Dec 31 2021 | US$5m | US$437k | -US$23m |
Compensación vs. Mercado: La compensación total de Tim($USD3.07M) está por encima de la media de empresas de tamaño similar en el mercado US ($USD649.07K).
Compensación vs. Ingresos: La compensación de Tim ha aumentado mientras la empresa no es rentable.
CEO
Tim Noyes (62 yo)
3.5yrs
Permanencia
US$3,070,657
Compensación
Mr. Timothy P. Noyes, MBA, also known as Tim, has been the Chief Executive Officer of Aerovate Therapeutics, Inc. since May 2021 and has been its Director since April 2021. Mr. Noyes serves as Venture Part...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| CEO & Director | 3.5yrs | US$3.07m | sin datos | |
| CFO & Treasurer | 3.7yrs | US$2.13m | 0.017% $ 13.4k | |
| Founder | 6.3yrs | US$2.88m | 0.049% $ 37.9k | |
| Chief Scientific Officer | 2.3yrs | US$433.20k | 0.0056% $ 4.3k | |
| Chief Medical Officer | 4.5yrs | US$1.63m | 0.019% $ 14.9k | |
| Head of Regulatory Affairs | 4.2yrs | sin datos | sin datos | |
| Executive Vice President of Development Operations | 2.6yrs | sin datos | sin datos | |
| Senior Vice President of Quality | 2.3yrs | sin datos | sin datos | |
| Executive Vice President of Clinical Development | 1.8yrs | sin datos | sin datos | |
| Senior Vice President of Clinical Development | 1.8yrs | sin datos | sin datos |
3.0yrs
Permanencia media
61yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de AVTE se considera experimentado (3 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| CEO & Director | 3.6yrs | US$3.07m | sin datos | |
| Independent Director | 1.3yrs | sin datos | sin datos | |
| Independent Director | 1.8yrs | US$568.54k | 0% $ 0 | |
| Independent Director | 4.3yrs | US$225.99k | 0% $ 0 | |
| Independent Director | 4.3yrs | US$174.80k | 0% $ 0 | |
| Independent Director | 3.8yrs | US$218.30k | 0% $ 0 | |
| Independent Director | 3.3yrs | US$185.80k | 0% $ 0 | |
| Independent Chairman of the Board | 1.3yrs | US$363.25k | 0% $ 0 |
3.5yrs
Permanencia media
57yo
Promedio de edad
Junta con experiencia: La junta directiva de AVTE se considera experimentada (3.5 años de antigüedad promedio).